APA (7th ed.) Citation

Kaufmann, P., Niglis, S., Bruderer, S., Segrestaa, J., Äänismaa, P., Halabi, A., & Dingemanse, J. (2015). Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects. British journal of clinical pharmacology, 80(4), 670-677. https://doi.org/10.1111/bcp.12650

Chicago Style (17th ed.) Citation

Kaufmann, Priska, Séverine Niglis, Shirin Bruderer, Jérôme Segrestaa, Päivi Äänismaa, Atef Halabi, and Jasper Dingemanse. "Effect of Lopinavir/ritonavir on the Pharmacokinetics of Selexipag an Oral Prostacyclin Receptor Agonist and Its Active Metabolite in Healthy Subjects." British Journal of Clinical Pharmacology 80, no. 4 (2015): 670-677. https://doi.org/10.1111/bcp.12650.

MLA (9th ed.) Citation

Kaufmann, Priska, et al. "Effect of Lopinavir/ritonavir on the Pharmacokinetics of Selexipag an Oral Prostacyclin Receptor Agonist and Its Active Metabolite in Healthy Subjects." British Journal of Clinical Pharmacology, vol. 80, no. 4, 2015, pp. 670-677, https://doi.org/10.1111/bcp.12650.